These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1549362

  • 1. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S, Maekawa M, Nakamura S.
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V.
    Cancer Res; 1995 Aug 15; 55(16):3569-75. PubMed ID: 7627966
    [Abstract] [Full Text] [Related]

  • 3. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J.
    Nature; 1992 Apr 23; 356(6371):713-5. PubMed ID: 1570015
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS, Hettich LA.
    Oncogene; 1993 Feb 23; 8(2):425-31. PubMed ID: 8426748
    [Abstract] [Full Text] [Related]

  • 5. Catalytic properties, tissue and intracellular distribution of neurofibromin.
    Golubić M, Roudebush M, Dobrowolski S, Wolfman A, Stacey DW.
    Oncogene; 1992 Nov 23; 7(11):2151-9. PubMed ID: 1437143
    [Abstract] [Full Text] [Related]

  • 6. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B, Bollag G, Shannon K.
    Am J Med Genet; 1999 Mar 26; 89(1):14-22. PubMed ID: 10469432
    [Abstract] [Full Text] [Related]

  • 7. Differential regulation of rasGAP and neurofibromatosis gene product activities.
    Bollag G, McCormick F.
    Nature; 1991 Jun 13; 351(6327):576-9. PubMed ID: 1904555
    [Abstract] [Full Text] [Related]

  • 8. Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.
    DiBattiste D, Golubic M, Stacey D, Wolfman A.
    Oncogene; 1993 Mar 13; 8(3):637-43. PubMed ID: 8437847
    [Abstract] [Full Text] [Related]

  • 9. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A, Griesser J, Horn D, Kaufmann D, Krone W, Nürnberg P.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):895-904. PubMed ID: 7575561
    [Abstract] [Full Text] [Related]

  • 10. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S, Bottorff D, Stone JC.
    Mol Carcinog; 1996 Jan 25; 15(1):64-9. PubMed ID: 8561868
    [Abstract] [Full Text] [Related]

  • 11. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP.
    Boyer MJ, Gutmann DH, Collins FS, Bar-Sagi D.
    Oncogene; 1994 Feb 25; 9(2):349-57. PubMed ID: 8290249
    [Abstract] [Full Text] [Related]

  • 12. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
    Nakamura T, Nemoto T, Arai M, Yamazaki Y, Kasuga T, Gutmann DH, Collins FS, Ishikawa T.
    Am J Pathol; 1994 Mar 25; 144(3):549-55. PubMed ID: 8129040
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
    Gutmann DH, Boguski M, Marchuk D, Wigler M, Collins FS, Ballester R.
    Oncogene; 1993 Mar 25; 8(3):761-9. PubMed ID: 8437860
    [Abstract] [Full Text] [Related]

  • 14. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR, Colman SD, Kousseff BG, Wallace MR.
    Hum Mutat; 1994 Mar 25; 3(4):347-52. PubMed ID: 8081387
    [Abstract] [Full Text] [Related]

  • 15. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues.
    Gutmann DH, Geist RT, Rose K, Wright DE.
    Dev Dyn; 1995 Mar 25; 202(3):302-11. PubMed ID: 7780179
    [Abstract] [Full Text] [Related]

  • 16. [NF1 (neurofibromatosis type 1)].
    Maruta H, Nur-e-Kamal.
    Gan To Kagaku Ryoho; 1997 Sep 25; 24(11):1422-6. PubMed ID: 9309135
    [Abstract] [Full Text] [Related]

  • 17. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
    Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G.
    Oncogene; 1996 Feb 01; 12(3):507-13. PubMed ID: 8637706
    [Abstract] [Full Text] [Related]

  • 18. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K.
    Nat Genet; 1996 Feb 01; 12(2):144-8. PubMed ID: 8563751
    [Abstract] [Full Text] [Related]

  • 19. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
    Hingtgen CM, Roy SL, Clapp DW.
    Neuroscience; 2006 Feb 01; 137(2):637-45. PubMed ID: 16298082
    [Abstract] [Full Text] [Related]

  • 20. [Molecular genetics of neurofibromatosis type 1].
    Suzuki H, Takahashi K, Shibahara S.
    Nihon Rinsho; 1993 Sep 01; 51(9):2457-61. PubMed ID: 8411728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.